DNOVO BIO
Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand. Its company's platform converts skin into functional brain cells. The company is currently operating in Stealth mode.
DNOVO BIO
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.dnovobio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.7 M USD
Similar Organizations
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Current Employees Featured
Founder
Investors List
Justin Mateen
Justin Mateen investment in Seed Round - dNovo Bio
Felicis Ventures
Felicis Ventures investment in Seed Round - dNovo Bio
Soma Capital
Soma Capital investment in Seed Round - dNovo Bio
Paul Buchheit
Paul Buchheit investment in Seed Round - dNovo Bio
Y Combinator
Y Combinator investment in Seed Round - dNovo Bio
Joey Krug
Joey Krug investment in Seed Round - dNovo Bio
Pioneer Fund
Pioneer Fund investment in Seed Round - dNovo Bio
Ataria
Ataria investment in Seed Round - dNovo Bio
Jason Hodges
Jason Hodges investment in Seed Round - dNovo Bio
Jean Pigozzi
Jean Pigozzi investment in Seed Round - dNovo Bio
Official Site Inspections
http://www.dnovobio.com Semrush global rank: 8.74 M Semrush visits lastest month: 261
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
